相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structure-guided changes at the V2 apex of HIV-1 Glade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies
Anusmita Sahoo et al.
CELL REPORTS (2022)
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs
Nanda Kishore Routhu et al.
IMMUNITY (2021)
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection
Tysheena P. Charles et al.
PLOS PATHOGENS (2021)
Current approaches to HIV vaccine development: a narrative review
Jiae Kim et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2021)
Structure-guided envelope trimer design in HIV-1 vaccine development: a narrative review
Ronald Derking et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2021)
HIV vaccinology: 2021 update
Jeong Hyun Lee et al.
SEMINARS IN IMMUNOLOGY (2021)
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
Kier Om et al.
PLOS PATHOGENS (2020)
Stabilized diverse HIV-1 envelope trimers for vaccine design
Qian Wang et al.
EMERGING MICROBES & INFECTIONS (2020)
HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge
Andrew T. Jones et al.
NATURE COMMUNICATIONS (2019)
Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge
Tiffany M. Styles et al.
JOURNAL OF VIROLOGY (2019)
Strong TH1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacy
Venkateswarlu Chamcha et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants
Samantha Burton et al.
JOURNAL OF VIROLOGY (2019)
Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
Thiago A. Patente et al.
FRONTIERS IN IMMUNOLOGY (2019)
Dendritic cell subsets in T cell programming: location dictates function
S. C. Eisenbarth
NATURE REVIEWS IMMUNOLOGY (2019)
Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors
Steven Tuyishime et al.
EBIOMEDICINE (2018)
Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope Trimers
Yoann Aldon et al.
CELL REPORTS (2018)
V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity
Charmaine van Eeden et al.
CELL REPORTS (2018)
Native-like Env trimers as a platform for HIV-1 vaccine design
Rogier W. Sanders et al.
IMMUNOLOGICAL REVIEWS (2017)
Coordinated protein co-expression in plants by harnessing the synergy between an intein and a viral 2A peptide
Bei Zhang et al.
PLANT BIOTECHNOLOGY JOURNAL (2017)
Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy
Rafiq Nabi et al.
PLOS ONE (2017)
Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers
Javier Guenaga et al.
JOURNAL OF VIROLOGY (2016)
High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques
Sunil Kannanganat et al.
JOURNAL OF IMMUNOLOGY (2016)
Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques
Smita S. Iyer et al.
JOURNAL OF VIROLOGY (2016)
Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability
Leopold Kong et al.
NATURE COMMUNICATIONS (2016)
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes
Steven W. de Taeye et al.
CELL (2015)
Codelivery of Envelope Protein in Alum with MVA Vaccine Induces CXCR3-Biased CXCR5+ and CXCR5- CD4 T Cell Responses in Rhesus Macaques
Smita S. Iyer et al.
JOURNAL OF IMMUNOLOGY (2015)
A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene
Pavel Pugach et al.
JOURNAL OF VIROLOGY (2015)
Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope
Katie M. Kilgore et al.
JOURNAL OF VIROLOGY (2015)
CD40L-Adjuvanted DNA/Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus ( SIV) Vaccine Enhances Protection against Neutralization-Resistant Mucosal SIV Infection
Suefen Kwa et al.
JOURNAL OF VIROLOGY (2015)
Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env
Young Do Kwon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses
Samantha L. Burton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens
Jean-Philippe Julien et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env
Young Do Kwon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Cleavage-Independent HIV-1 Env Trimers Engineered as Soluble Native Spike Mimetics for Vaccine Design
Shailendra Kumar Sharma et al.
CELL REPORTS (2015)
CD40L-Adjuvanted DNA/Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE660 Mucosal Challenge
Suefen Kwa et al.
JOURNAL OF VIROLOGY (2014)
Cryptic Determinant of alpha 4 beta 7 Binding in the V2 Loop of HIV-1 gp120
Boonrat Tassaneetrithep et al.
PLOS ONE (2014)
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
Hua-Xin Liao et al.
IMMUNITY (2013)
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
Rogier W. Sanders et al.
PLOS PATHOGENS (2013)
A Novel Assay for Antibody-Dependent Cell-Mediated Cytotoxicity against HIV-1-or SIV-Infected Cells Reveals Incomplete Overlap with Antibodies Measured by Neutralization and Binding Assays
Michael D. Alpert et al.
JOURNAL OF VIROLOGY (2012)
SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses
Lilin Lai et al.
VACCINE (2012)
Preexisting Vaccinia Virus Immunity Decreases SIV-Specific Cellular Immunity but Does Not Diminish Humoral Immunity and Efficacy of a DNA/MVA Vaccine
Sunil Kannanganat et al.
JOURNAL OF IMMUNOLOGY (2010)
Nonpathogenic Simian Immunodeficiency Virus Infection of Sooty Mangabeys Is Not Associated with High Levels of Autologous Neutralizing Antibodies
Bing Li et al.
JOURNAL OF VIROLOGY (2010)
Contributions of Mamu-A*01 Status and TRIM5 Allele Expression, But Not CCL3L Copy Number Variation, to the Control of SIVmac251 Replication in Indian-Origin Rhesus Monkeys
So-Yon Lim et al.
PLOS GENETICS (2010)
Preclinical Studies of Human Immunodeficiency Virus/AIDS Vaccines: Inverse Correlation between Avidity of Anti-Env Antibodies and Peak Postchallenge Viremia
Jun Zhao et al.
JOURNAL OF VIROLOGY (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Impact of MHC class I diversity on immune control of immunodeficiency virus replication
Philip J. R. Goulder et al.
NATURE REVIEWS IMMUNOLOGY (2008)
GM-CSF DNA:: An adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine
Lilin Lai et al.
VIROLOGY (2007)
Molecularly cloned SHIV-1157ipd3N4:: a highly replication-competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C env
R. J. Song et al.
JOURNAL OF VIROLOGY (2006)
Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6p challenge in Mamu-A*01-negative rhesus monkeys
XP Liang et al.
JOURNAL OF VIROLOGY (2005)
Regulation of dendritic cell migration to the draining lymph node:: Impact on T lymphocyte traffic and priming
A Martín-Fontecha et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication
BR Mothé et al.
JOURNAL OF VIROLOGY (2003)
Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines
RR Amara et al.
JOURNAL OF VIROLOGY (2002)
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency
R Pal et al.
JOURNAL OF VIROLOGY (2002)
分享论文
